drugset / Trial / NCT00678379

Pediatric Tonsillectomy Pain Reduction Study

NCT00678379

Phase 3 Completed 120 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Tonsillectomy is associated with a significant decrease quality of life in children secondary to pain, which is worsened with swallowing. The objective of the current study is to conduct a prospective, double-blind, placebo-controlled, randomized clinical trial using a pre-tonsillectomy infiltration of the tonsillar fossa comparing three treatment regimens in reducing post-tonsillectomy morbidity (i.e. pain, poor oral intake): 1) Placebo (saline injection) 2) bupivacaine (0.5%) + lidocaine (1%), 3) bupivacaine (0.5%) + lidocaine (1%) + clonidine (25 µg).

Timeline

Start
2008-04
Primary completion
2009-11
Completion
2009-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.5 % Other
Subject Clonidine Other / unclassified 25 ug Other
Comparator Lidocaine Other / unclassified 1 % Other

Indications

No indication recorded.